Intrareservoir Administration of Alteplase to Treat a Distal Ventriculoatrial Shunt Obstruction.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 31 08 2019
accepted: 04 11 2019
pubmed: 13 11 2019
medline: 27 3 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

Ventriculoatrial shunts can be afflicted with distal malfunctions due to thrombus formation at the distal tip. Distal tip thrombus formation may occur more commonly in oncologic patients who are predisposed to hypercoagulability. A patient who had a ventriculoatrial shunt placed for leptomeningeal carcinomatosis presented with headaches and confusion and was found to have a partial distal shunt obstruction. Intrareservoir administration of alteplase resulted in resolution of her symptoms. Nuclear medicine shunt patency test demonstrated restoration of distal flow. Intrareservoir administration of alteplase can be a useful nonoperative treatment strategy for ventriculoatrial shunt malfunction. This strategy may be particularly useful in cases with higher perioperative risk, such as patients with advanced metastatic cancer.

Sections du résumé

BACKGROUND BACKGROUND
Ventriculoatrial shunts can be afflicted with distal malfunctions due to thrombus formation at the distal tip. Distal tip thrombus formation may occur more commonly in oncologic patients who are predisposed to hypercoagulability.
CASE DESCRIPTION METHODS
A patient who had a ventriculoatrial shunt placed for leptomeningeal carcinomatosis presented with headaches and confusion and was found to have a partial distal shunt obstruction. Intrareservoir administration of alteplase resulted in resolution of her symptoms. Nuclear medicine shunt patency test demonstrated restoration of distal flow.
CONCLUSIONS CONCLUSIONS
Intrareservoir administration of alteplase can be a useful nonoperative treatment strategy for ventriculoatrial shunt malfunction. This strategy may be particularly useful in cases with higher perioperative risk, such as patients with advanced metastatic cancer.

Identifiants

pubmed: 31715416
pii: S1878-8750(19)32849-9
doi: 10.1016/j.wneu.2019.11.013
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0
Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-261

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Nader Delavari (N)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA. Electronic address: Teresa.Hidalgo@nyumc.org.

Monica C Mureb (MC)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.

Amanda Yaun (A)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.

Jeffrey H Wisoff (JH)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.

David H Harter (DH)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.

E Teresa Hidalgo (ET)

Department of Neurosurgery, New York University School of Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH